GLP-1s and Blinding Condition; Cyclosporiasis Source Found? Tylenol-Autism Lawsuits

A cohort study found diabetes patients taking GLP-1 receptor agonists had a higher risk of anterior ischemic optic neuropathy, a potentially blinding eye condition. The article also mentions Tylenol-autism lawsuits and an investigation into the source of cyclosporiasis, though details on these topics are not elaborated in the provided content.